tirzepatide obesity trial non-diabetic in people with and without type 2 diabetes | PPA Safety and Effectiveness of Tirzepatide
Description
A label might read 10 mg/mL tirzepatide + 1 mg/mL B12 in a 2 mL vial, or it might read the total active compound concentration differently
This medication belongs to a class of drugs known as dual GLP-1 and GIP receptor agonists
Rotating injection sites is crucial to prevent cumulative irritation
00656-2/asset/38c98550-9ec2-44e8-ba6a-dbb815075666/main.assets/gr1_lrg.jpg)
Aggregated peptide is not just less effective
Bruising and Discoloration While not everyone experiences it, bruising is a regular talking point in user forums - often appearing after an otherwise smooth injection
